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BACKGROUND and aim: Immunization with live virus
vaccines may cause an immunosuppression with
lymphopaenia, impaired cytokine production and
defective lymphocyte response to mitogenes. These
abnormalities were described in subjects vaccinated
against measles. This study was performed to analyse
the host immune response related to immunosup-
pression in subjects vaccinated with live attenuated
rubella vaccine.
Methods: Eighteen schoolgirls, aged 11 
/13 years,
were vaccinated with live attenuated rubella vaccine
Rudivax
†
. Before immunization, and 7 and 30 days
after, peripheral blood was collected. Cellular frac-
tions were subjected to flow cytometric analysis, and
the lymphocyte response to phytohaemagglutinin
was investigated. Plasma samples were analysed for
cytokines (interleukin (IL)-4, IL-10, tumour necrosis
factor-a, and interferon-g) by enzyme-linked immu-
nosorbent assay techniques.
Results: On day 7 after vaccination, the number of
each lymphocyte subset was decreased; however,
only for CD3 and CD4 lymphocytes has a significant
reduction been shown. On the contrary, tumour
necrosis factor-a and IL-10 levels markedly increased
and amounted to its maximum on day 30. Simulta-
neously, a significant reduction in plasma interferon-
g and a profound decrease of the lymphocyte re-
sponse to phytohaemagglutinin were shown. The
changes were accompanied with marked elevation
of plasma IL-4.
Conclusions: Our data indicate that the vaccination
with live attenuated rubella vaccine results in mod-
erate but sustained immune disturbance. The signs of
immunosuppression, including defective lymphocyte
response to mitogene and impaired cytokine produc-
tion, may persist for at least 1 month after vaccina-
tion.
Key words: IFNg, IL-4, IL-10, Immunosuppression, Lym-
phocyte response to phytohaemagglutinin, Lymphocyte
subsets, Rubella vaccine, TNF-a, Vaccination
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Introduction
Natural rubella virus infection is characterized by
fever, sore throat, lymphadenopathy, and skin rash,
which usually resolve quickly.
1 It has been estimated
that about one-half of all rubella virus infections are
clinically inapparent
2 and would only be detected
serologically.
3,4 Since maternal rubella infection dur-
ing the first trimester of pregnancy may result in
spontaneous abortion or in foetal infection, leading
to serious birth defects,
5 it has become routine
practice to offer immunization to all seronegative
women of childbearing age as well as to infants.
When such vaccination programmes have been
undertaken, the incidence of reported rubella and
congenital rubella syndrome has declined.
4 Despite
the fact that the epidemiology of rubella has changed
significantly in the past decade, it is generally agreed
that the current strategy of vaccination must be
enhanced.
6 It is well known that immunization with
live virus vaccines may cause slight but not negligible
clinical manifestations such as fever, skin rash and
immunosuppression with lymphopaenia, impaired
cytokine production and defective lymphocyte re-
sponse to mitogenes.
7 9 These abnormalities have
been described in detail in subjects vaccinated
against measles.
This study aimed to analyse the host immune
response related to immunosuppression in subjects
vaccinated with live attenuated rubella vaccine.
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Subject assessment
The study group included 18 schoolgirls, aged 11 /13
years, with a negative history of rubella. All subjects
had routine physical examination and rubella ser-
otesting. None of the participants were seropositive.
Girls were vaccinated with live attenuated rubella
vaccine Rudivax
†
(Aventis Pasteur, Lyon, France). No
vaccine-related adverse effects were noted. Blood
samples were collected before vaccination, and then
again 1 week and 1 month later. All study subjects
showed protective titres of immunoglobulin G,
defined as  /1:400, after immunization. The study
was approved by the Ethics Committee of the
Moscow G.N. Gabrichevsky Institute of Epidemiol-
ogy and Microbiology.
Blood collection
Blood was collected in tubes with heparin (25 IU/ml)
by venopuncture.
Flow cytometry
Mononuclear cells were isolated from heparinized
peripheral blood by Ficoll-Verographin density gra-
dient centrifugation. Cellular fractions were subjected
to flow cytometric analysis (FACSCalibur, Becton-
Dickinson, Franklin Lakes, NJ, USA) for counting
absolute numbers of cell populations. The samples
were treated directly with five monoclonal antibodies
labelled with fluorescein isothiocyanate (CD3/CD4/
CD8/CD16/CD19; SORBENT, Moscow, Russia) for
analysing lymphocyte subsets.
Cytokine assay
Plasma samples were harvested and analysed for
cytokines by enzyme-linked immunosorbent assay
techniques with commercially available kits (Cytim-
mune Science Inc., College Park, MD, USA). The
enzyme-linked immunosorbent assay kits for inter-
leukin (IL)-4, tumour necrosis factor-a (TNF-a) and
IL-10 were designed to measure the ‘total’ (bound
and unbound) amount of the cytokines. The kit for
interferon-g (IFNg) was designed to measure the
‘free’ forms of the cytokine.
Peripheral blood lymphocyte response to
phytohaemagglutinin
Mononuclear cells were isolated from heparinized
peripheral blood by Ficoll-Verographin density gra-
dient centrifugation. The cells were washed twice
and re-suspended in RPMI-1640 medium supplemen-
ted with 10% heat-inactivated donor horse serum,
2 /10
 3 M of HEPES, 2 mM of L-glutamine, 2.8 /
10
 6 M of 2-mercaptoethanol, and 20 mg/ml of
gentamycin. The cells were cultivated in flat-bot-
tomed 96-well plates, and contained 5 /10
4 cells in
each well. The final concentration of phytohaemag-
glutinin (PHA) was 5 mg/ml. The cells were incubated
for 72 h at 378C in a humidified atmosphere contain-
ing 5% CO2. Four hours before the end of cultivation,
each well was pulsed with 40 kBq of [
3H]-thymidine.
The cells were harvested with a cell harvester and
counted on a liquid scintillation counter. Triplicate
wells were assayed and the counts per minute were
averaged.
Statistical analysis
Statistical analysis was performed using non-para-
metric Wilcoxon tests.
Results
Lymphocyte subsets
Absolute numbers of total lymphocytes and lympho-
cyte subsets were determined for peripheral blood of
vaccine recipients as described in Materials and
methods. Results obtained before and after vaccina-
tion are presented in Table 1. It was noted that on day
7 after vaccination, average numbers of total lym-
phocytes and each subsets were relatively decreased
compared with initial levels. However, only for CD3
and CD4 lymphocyte subsets has a significant reduc-
tion been revealed. The numbers of total lymphocyte
and T-cell subsets tended to recover to the normal
ranges within 1 month, whereas the number of B
cells remained at a low level.
Plasma cytokines
As can be seen in Fig. 1, a transient increase of IFNg
levels on day 7 after rubella vaccine inoculation has
been observed (p /0.028). One month later, this
parameter did reduce dramatically, down to 0 in
several subjects (p /0.009). Fig. 2 illustrates the
individual variations in IL-4 levels measured before
vaccination and then again 7 and 30 days after.
Significant elevation of the cytokine levels at day 30
after vaccine inoculation was found.
We further investigated the plasma concentration
of TNF-a and IL-10, a pair of cytokines that play
opposite roles in the immune response. After rubella
vaccination, a marked increase in both IL-10 and
TNF-a concentrations has been observed (Fig. 3).
The relative concentrations of plasma TNF-a and IL-
10 were also calculated. Before vaccination, most
children (13 of 18) exhibited a relatively high
cytokine ratio (median value, 1.56). On day 7 after
A. L. Pukhalsky et al.
204 Mediators of Inflammation Vol 12  2003immunization, a rise in IL-10 passed ahead of TNF-a
expansion. In this context, a significant decrease in
the TNF-a/IL-10 ratio was observed (median value,
0.65; p /0.05). On day 30 after rubella vaccination,
IL-10 still predominated over TNF-a and the median
value of the cytokine ratio did not exceed 0.52 (p /
0.02).
Proliferative response to PHA
The influence of rubella vaccine inoculation upon
PHA-induced peripheral blood lymphocyte response
is summarized in Table 2. There were no significant
differences in levels of T-lymphocyte proliferation
before vaccination and 7 days later. At the same time,
Table 1. Effect of rubella vaccination on numbers of lymphocytes in the peripheral blood (absolute lymphocyte count/ml)
Before inoculation 7 days after inoculation 30 days after inoculation
Total lymphocytes 20469 /161 16179 /159 18689 /109
CD3
  12149 /110 9369 /85* 11189 /60
CD4
  7479 /68 5509 /59** 6599 /48
CD8
  4819 /51 3769 /36 4449 /40
CD4/CD8 1.619 /0.11 1.559 /0.15 1.589 /0.14
CD16
  3409 /34 2579 /34 2869 /28
CD19
  4489 /61 3929 /64 3839 /53
Data presented as the mean9 /standard error of the mean.
*p /0.05, ** p /0.038 using the paired Wilcoxon test.
FIG. 1. IFNg dynamics after live attenuated rubella vaccine inoculation. Results are expressed as the mean9 /standard error of
the mean. Data reported were compared by the two-sample Wilcoxon test.
FIG. 2. Individual variations in IL-4 levels after rubella vaccine inoculation. The median values are designated with horizontal
lines. Each dot represents one subject. The data were analysed using the two-sample Wilcoxon test.
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day 30 following vaccination was observed.
Discussion
The immune response to virus infections and atte-
nuated virus vaccines seems to depend on various
factors including genetics, age and sex. Thus, measles
patients of 1 /2 years of age are least severe in clinical
symptoms and lymphopaenia, whereas young infants
before their first birthday as well as adolescents and
adults will progress to severe conditions.
10 Studies
from Guinea-Bissau and South Africa have observed
increased mortality due to measles in girls,
11,12 and
girls are more likely to develop fever and rash after
routine measles /mumps /rubella immunization.
13
Similarly to measles vaccine recipients,
14 most
schoolgirls enrolled in our study demonstrated mod-
erate lymphopenia after rubella vaccine inoculation.
In particular, on day 7 after vaccination the number of
each lymphocyte subset was decreased compared
with the initial level, and for CD3 and CD4 lympho-
cyte subsets a significant reduction has been re-
vealed. The mechanism by which the numbers of
lymphocytes are decreased during viral diseases and
after vaccine inoculation is unclear. Some authors
postulate that transient lymphopaenia arises from
virus-induced death of T cells.
10 Another potential
mechanism for change in the number of circulating
lymphocytes may be associated with alterations in
lymphocyte trafficking, which related to increased
production of IFNg.
15,16 It is significant that in our
study on day 7 after rubella vaccination, transient
elevation in plasma IFNg has been observed (see Fig.
1).
In contrast to the rubella patients demonstrating a
transient increase in IL-10 level,
17 a sustained eleva-
tion of the cytokine concentration in rubella vaccine
recipients has been found. The IL-10 levels increased
as early as day 7 and amounted to a maximum on day
30. Simultaneously, a significant reduction in plasma
IFNg and a profound decrease of peripheral blood
lymphocyte response to PHA have been shown.
These changes were accompanied with marked
elevation of IL-4. It may be proposed that the
observed cytokine ‘shift’ from type 1 cytokines early
after vaccine inoculation to type 2 cytokines 1 month
after vaccination is associated with activation of
central mechanisms of immunosuppression. This
assumption is indirectly confirmed by changes in
TNF-a/IL-10 ratios after rubella vaccine inoculation.
Thus, before vaccination, most girls (13 of 18)
exhibited relatively high cytokine ratios (TNF-a/IL-
10 /1), demonstrating predominance of pro-inflam-
matory TNF-a over anti-inflammatory IL-10. Rubella
vaccination and associated stress were bound to
result in catecholamine and corticosteroid releasing
that promoted IL-4 and IL-10 synthesis.
18 Besides,
auxiliary sources of anti-inflammatory IL-10 (such as
liver, spleen and brain as well) might be acti-
vated.
19,20 Thereafter, on day 7 after immunization,
a rise in IL-10 passed ahead of TNF-a expansion. In
this context, a significant decrease of TNF-a/IL-10
ratios has been observed. On day 30 after rubella
vaccination IL-10 still predominated over TNF-a,
suggesting moderate but sustained immune distur-
bance.
In conclusion, live attenuated rubella vaccine
inoculation may cause sustained immunosuppression
including defective lymphocyte response to mito-
gene and impaired cytokine production. The signs of
immunosuppression may persist for at least 1 month
after vaccination.
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